Global project reveals cancer’s genomic playbookFebruary 5, 2020Mixed TopicsCNS/Brain CancerBreast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersGynecologic Cancer
ECHELON-1 update: A+AVD bests ABVD in Hodgkin lymphomaFebruary 1, 2020Lymphoma & Plasma Cell Disorders
Adding lymphopenia component ‘improves’ FLIPIJanuary 24, 2020Follicular LymphomaLymphoma & Plasma Cell Disorders
Experts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020Immuno-oncologyImmunotherapyLymphoma & Plasma Cell Disorders
Start of myeloma therapy may be delayed for women, minoritiesJanuary 21, 2020Lymphoma & Plasma Cell Disorders
CAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020Mixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Adult survivors of childhood cancer are experiencing fewer major cardiac eventsJanuary 21, 2020Preventive CareLymphoma & Plasma Cell Disorders
REGN1979 shows good activity in pretreated aggressive B-NHLJanuary 15, 2020Follicular LymphomaDLBCLLymphoma & Plasma Cell Disorders
NCCN guidelines highlight ‘complicated’ treatment for pediatric lymphomasJanuary 14, 2020PediatricsDLBCLLymphoma & Plasma Cell Disorders
CAR T cells produce complete responses in T-cell malignanciesJanuary 7, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncology
Inhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patientsDecember 23, 2019ImmunotherapyLymphoma & Plasma Cell DisordersImmuno-oncology
LOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignanciesDecember 20, 2019Lymphoma & Plasma Cell Disorders
Survival data reported from largest CAR T trial in B-cell lymphomaDecember 20, 2019Lymphoma & Plasma Cell DisordersDLBCLFollicular LymphomaImmuno-oncologyImmunotherapy
D-RVd for frontline myeloma looks robust in GRIFFIN trial updateDecember 17, 2019Lymphoma & Plasma Cell Disorders
Some MCL patients can safely stop venetoclax-ibrutinib, study suggestsDecember 14, 2019Lymphoma & Plasma Cell Disorders
